Baron & Budd Finalizes $774 Million Settlement With Albertsons in Nationwide Opioid Litigation

Baron & Budd has completed settlement negotiations with Albertsons Companies, a major pharmacy operator, for $774 million to resolve allegations and claims arising from the company's distribution and sale of opioid medications in the nationwide opioid litigation. The settlement represents a significant recovery in the multidistrict litigation targeting major pharmacy chains, distributors, and manufacturers for their roles in fueling the opioid epidemic. This follows a series of similar settlements with other pharmacy defendants and represents continued progress in resolving claims brought on behalf of governmental entities and individuals harmed by widespread opioid distribution practices.

This is a curated brief from the PlaintiffWire news desk. Read the original report at Business Wire.